Good news for diabetes patients! A Stanford research team has developed a two-in-one shot that may help diabetics better control their blood sugar levels. The injection contains insulin in combination with a drug based on a second hormone known as amylin. This hormone plays a synergistic role with insulin to control blood sugar levels after eating. The amylin-based drug is already commercially available. But it is estimated that only a few diabetics taking insulin therapy (less than 1 percent) also take this complementary treatment. This is because the two hormones are too unstable to coexist in the same syringe. Taking